SCHEMBL8487111

SCHEMBL8487111

C[C@@H](C(=O)O)N(Cc1ccc2nc(-c3ccccc3-c3nnn[nH]3)ccc2c1)C(=O)C1CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 2/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ABL1 P00519 1/20 0.32
ITGB1 P05556 1/20 0.32
ITGAV P06756 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KCNH2 Q12809 4/20 0.31
SLC6A2 P23975 3/20 0.31
SLC6A4 P31645 3/20 0.31
SLC6A3 Q01959 3/20 0.31
NPSR1 Q6W5P4 2/20 0.31
KDM4E B2RXH2 1/20 0.31
APAF1 O14727 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8482164 0.98 TSHR (0.35) AGTR1LMNATSHRPKMSMN1; SMN2
SCHEMBL8486216 0.93 AGTR1 (0.36) AGTR1LMNATSHRPKMSMN1; SMN2
SCHEMBL8486280 0.90 AGTR1 (0.35) AGTR1LMNATSHROPRM1OPRD1
SCHEMBL8483014 0.90 AGTR1 (0.35) AGTR1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL8483656 0.90 AGTR1 (0.36) AGTR1OPRM1OPRD1KCNH2SLC6A2
SCHEMBL8488255 0.89 AGTR1 (0.41) AGTR1TSHRSMN1; SMN2ITGB1ITGAV
SCHEMBL8481923 0.87 AGTR1 (0.41) AGTR1LMNATSHRABL1OPRM1
SCHEMBL8487828 0.87 AGTR1 (0.45) AGTR1LMNAMEN1KMT2A
SCHEMBL8481890 0.86 ALDH1A1 (0.39) AGTR1LMNAHSD17B10
SCHEMBL8488705 0.85 AGTR1 (0.40) AGTR1TSHRABL1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5955487-A TREATING HIGH BLOOD PRESSURE, CARDIAC INSUFFICIENCY, GLAUCOMA CIBA-GEIGY CORPORATION (US) 1999-09-21 US disclosed
EP-0528762-B1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
US-5620998-A CARDIOVASCULAR DISORDERS; HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1997-04-15 US disclosed
US-5506240-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
EP-0528762-A1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists CIBA-GEIGY AG (CH) 1993-02-24 EP disclosed